| 1 |
Artis D, Spits H. The biology of innate lymphoid cells[J]. Nature, 2015, 517 (7534): 293-301.
|
| 2 |
Sonnenberg GF, Artis D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation[J]. Nat Med, 2015, 21 (7): 698-708.
|
| 3 |
Klose CS, Artis D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis[J]. Nat Immunol, 2016, 17 (7): 765-774.
|
| 4 |
李镇文，杨想平，唐朝晖.固有免疫反应在严重多发伤后机体免疫麻痹中的核心作用[J/CD].中华危重症医学杂志（电子版），2021，14（3）：248-251.
|
| 5 |
Eberl G, Colonna M, Di Santo JP, et al. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology[J]. Science, 2015, 348 (6237): aaa6566.
|
| 6 |
Vivier E, Artis D, Colonna M, et al. Innate lymphoid cells: 10 years on[J]. Cell, 2018, 174 (5): 1054-1066.
|
| 7 |
Montaldo E, Vacca P, Vitale C, et al. Human innate lymphoid cells[J]. Immunol Lett, 2016 (179): 2-8.
|
| 8 |
Constantinides MG, McDonald BD, Verhoef PA, et al. A committed precursor to innate lymphoid cells[J]. Nature, 2014, 508 (7496): 397-401.
|
| 9 |
Klose CSN, Flach M, Mohle L, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages[J]. Cell, 2014, 157 (2): 340-356.
|
| 10 |
Zhong C, Zheng M, Cui K, et al. Differential expression of the transcription factor GATA3 specifies lineage and functions of innate lymphoid cells[J]. Immunity, 2020, 52 (1): 83-95.e4.
|
| 11 |
Moretta F, Petronelli F, Lucarelli B, et al. The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF[J]. Eur J Immunol, 2016, 46 (5): 1271-1278.
|
| 12 |
Munneke JM, Bjorklund AT, Mjosberg JM, et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease[J]. Blood, 2014, 124 (5): 812-821.
|
| 13 |
Lim AI, Li Y, Lopez-Lastra S, et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation[J]. Cell, 2017, 168 (6): 1086-1100.e10.
|
| 14 |
Zhao T, Li Y, Liu B, et al. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model[J]. J Trauma Acute Care Surg, 2016, 80 (1): 34-40; discussion 40-41.
|
| 15 |
Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune defence[J]. Nat Rev Immunol, 2016, 16 (2): 79-89.
|
| 16 |
Moro K, Kabata H, Tanabe M, et al. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses[J]. Nat Immunol, 2016, 17 (1): 76-86.
|
| 17 |
Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus[J]. Nat Immunol, 2011, 12 (11): 1045-1054.
|
| 18 |
Abt MC, Lewis BB, Caballero S, et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute clostridium difficile infection[J]. Cell Host Microbe, 2015, 18 (1): 27-37.
|
| 19 |
Quatrini L, Wieduwild E, Guia S, et al. Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells[J]. J Exp Med, 2017, 214 (12): 3531-3541.
|
| 20 |
Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity[J]. Annu Rev Immunol, 2014 (32): 659-702.
|
| 21 |
Stehle C, Rückert T, Fiancette R, et al. T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation[J]. Nat Immunol, 2021, 22 (10): 1231-1244.
|
| 22 |
O'Sullivan TE, Rapp M, Fan X, et al. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance[J]. Immunity, 2016, 45 (2): 428-441.
|
| 23 |
Gasteiger G, Fan X, Dikiy S, et al. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs[J]. Science, 2015, 350 (6263): 981-985.
|
| 24 |
Zhu J. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production[J]. Cytokine, 2015, 75 (1): 14-24.
|
| 25 |
吴瑶，祝筱梅，郭方，等. Ⅱ型固有淋巴细胞在炎症性疾病中的作用及意义[J].中华急诊医学杂志，2021，30（7）：907-911.
|
| 26 |
Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease[J]. Nat Rev Immunol, 2016, 16 (11): 676-689.
|
| 27 |
Bessa J, Meyer CA, de Vera Mudry MC, et al. Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation[J]. J Autoimmun, 2014 (55): 33-41.
|
| 28 |
Stier MT, Zhang J, Goleniewska K, et al. IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow[J]. J Exp Med, 2018, 215 (1): 263-281.
|
| 29 |
Chun TT, Chung CS, Fallon EA, et al. Group 2 innate lymphoid cells (ILC2s) are key mediators of the inflammatory response in polymicrobial sepsis[J]. Am J Pathol, 2018, 188 (9): 2097-2108.
|
| 30 |
Lai D, Tang J, Chen L, et al. Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis[J]. Cell Death Dis, 2018, 9 (3): 369.
|
| 31 |
Ito I, Bhopale KK, Kobayashi M, et al. Lamina propria group 2 innate lymphoid cells impair the antibacterial defense of burned mice to enterococcal translocation[J]. J Leukoc Biol, 2017, 102 (6): 1451-1460.
|
| 32 |
Chen W, Lai D, Li Y, et al. Neuronal-activated ILC2s promote IL-17A production in lung γδ T cells during sepsis[J]. Front Immunol, 2021 (12): 670676
|
| 33 |
Bruchard M, Geindreau M, Perrichet A, et al. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses[J]. Nat Immunol, 2022, 23 (2): 262-274.
|
| 34 |
Rankin LC, Girard-Madoux MJ, Seillet C, et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells[J]. Nat Immunol, 2016, 17 (2): 179-186.
|
| 35 |
Lim AI, Di Santo JP. ILC-poiesis: ensuring tissue ILC differentiation at the right place and time[J]. Eur J Immunol, 2019, 49 (1): 11-18.
|
| 36 |
Hepworth MR, Monticelli LA, Fung TC, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria[J]. Nature, 2013, 498 (7452): 113-117.
|
| 37 |
Mortha A, Chudnovskiy A, Hashimoto D, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis[J]. Science, 2014, 343 (6178): 1249288.
|
| 38 |
Carvelli J, Piperoglou C, Bourenne J, et al. Imbalance of circulating innate lymphoid cell subpopulations in patients with septic shock[J]. Front Immunol, 2019 (10): 2179.
|
| 39 |
Lim AI, Verrier T, Vosshenrich CA, et al. Developmental options and functional plasticity of innate lymphoid cells[J]. Curr Opin Immunol, 2017 (44): 61-68.
|
| 40 |
Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, et al. Toll-like receptors expression and interferon-γ production by NK cells in human sepsis[J]. Crit Care, 2012, 16 (5): R206.
|
| 41 |
Guo Y, Patil NK, Luan L, et al. The biology of natural killer cells during sepsis[J]. Immunology, 2018, 153 (2): 190-202.
|
| 42 |
Hiraki S, Ono S, Kinoshita M, et al. Neutralization of IL-10 restores the downregulation of IL-18 receptor on natural killer cells and interferon-γ production in septic mice, thus leading to an improved survival[J]. Shock, 2012, 37 (2): 177-182.
|
| 43 |
陈敏，袁佳辉，郭冬阳，等. CXC趋化因子配体12/CXC趋化因子受体4轴在脓毒症中的研究进展[J/CD].中华危重症医学杂志（电子版），2020，12（3）：225-228.
|
| 44 |
Pastille E, Pohlmann S, Wirsdorfer F, et al. A disturbed interaction with accessory cells upon opportunistic infection with Pseudomonas aeruginosa contributes to an impaired IFN-gamma production of NK cells in the lung during sepsis-induced immunosuppression[J]. Innate Immun, 2015, 21 (2): 115-126.
|
| 45 |
Zang J, Ye J, Zhang C, et al. Senescent hepatocytes enhance natural killer cell activity via the CXCL-10/CXCR3 axis[J]. Exp Ther Med, 2019, 18 (5): 3845-3852.
|